Marina Sekacheva

I.M. Sechenov First Moscow State Medical University

Trubetskaya ul., 8

Moscow, Moscow 119991

Russia

SCHOLARLY PAPERS

3

DOWNLOADS

160

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Establishment of CORONET: COVID-19 Risk in Oncology Evaluation Tool to Identify Cancer Patients at Low Versus High Risk of Severe Complications of COVID-19 Infection Upon Presentation to Hospital

Number of pages: 51 Posted: 28 Jul 2021
The Christie NHS Foundation Trust, The University of Manchester, University of Manchester - Digital Experimental Cancer Medicine, affiliation not provided to SSRN, The University of Manchester, The University of Manchester, The University of Manchester, affiliation not provided to SSRN, ITG, Inc. - ITG London, affiliation not provided to SSRN, Manchester Academic Health Sciences Centre - The Christie NHS Foundation Trust, University of Dundee, affiliation not provided to SSRN, affiliation not provided to SSRN, Manchester Academic Health Sciences Centre - The Christie NHS Foundation Trust, Hospital General Universitario Gregorio Marañón, affiliation not provided to SSRN, University of Southampton - University Hospital Southampton NHS Foundation Trust, Fundeni Clinical Institute, Lahey Hospital and Medical Center - Division of Cardiovascular Medicine, affiliation not provided to SSRN, University Hospitals Plymouth NHS Trust, University of Manchester - Digital Experimental Cancer Medicine, University of Manchester - Digital Experimental Cancer Medicine, Lahey Hospital and Medical Center - Division of Cardiovascular Medicine, affiliation not provided to SSRN, The Christie NHS Foundation Trust, affiliation not provided to SSRN, affiliation not provided to SSRN, NHS Foundation Trust - Royal Marsden Hospital, Ninewells Hospital and Medical School, affiliation not provided to SSRN, University of Manchester - Research IT, affiliation not provided to SSRN, affiliation not provided to SSRN, University College London Hospital, Government of the United Kingdom - Oncology Department, Clatterbridge Cancer Centre, University College London - UCL Cancer Institute, Sheffield Teaching Hospitals NHS Foundation Trust, University of Southampton - Cancer Sciences Academic Unit, University of Lausanne - Lausanne University Hospital, Lahey Hospital and Medical Center, affiliation not provided to SSRN, Lahey Hospital and Medical Center - Department of Internal Medicine, affiliation not provided to SSRN, Centre Hospitalier Universitaire Vaudois (CHUV), Lahey Hospital and Medical Center, Bristol Haematology and Oncology Centre, affiliation not provided to SSRN, PSL Research University - Institut Curie, Royal Cornwall Hospital - Sunrise Centre, I.M. Sechenov First Moscow State Medical University, affiliation not provided to SSRN, affiliation not provided to SSRN, National Institute for Health Research (NIHR), Government of the United Kingdom - Oncology Department, University of Liverpool - NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Hospital Universitario La Paz - Department of Medical Oncology, The Christie NHS Foundation Trust, Government of the United Kingdom - Weston Park Cancer Centre, Government of the United Kingdom - Weston Park Cancer Centre, affiliation not provided to SSRN, affiliation not provided to SSRN, The Christie NHS Foundation Trust, Independent, The University of Manchester, The University of Manchester and The Christie NHS Foundation Trust
Downloads 106 (525,121)

Abstract:

Loading...

COVID-19, cancer, SARS-CoV-2, decision support tool; CORONET

2.

Transcriptomics in Tumor and Normal Tissues and Precision Oncology Algorithms Identify Early-Stage NSCLC Patients with High Risk of Post-Surgery Recurrence Who May Benefit from Adjuvant Therapies

Number of pages: 28 Posted: 24 Aug 2021
WIN Consortium - Worldwide Innovative Network (WIN) Association, Groupe Hospitalier Saint-Joseph, École Normale Supérieure - PSL Research University - Institut Curie, Pfizer, Inc., AstraZeneca Pharmaceuticals, WIN Consortium - Worldwide Innovative Network (WIN) Association, WIN Consortium - Worldwide Innovative Network (WIN) Association, Avera Cancer Institute, WIN Consortium - Worldwide Innovative Network (WIN) Association, Hebrew University of Jerusalem - The Sharett Institute of Oncology, Chaim Sheba Medical Center, Chaim Sheba Medical Center, Fudan University - Department of Thoracic SurgeryFudan University - Shanghai Cancer Center, King Hussein Cancer Center (KHCC), Tokyo Medical and Dental University, University of Copenhagen - Rigshospitalet, I.M. Sechenov First Moscow State Medical University, Hospital Vall d’Hebron, Vall d’Hebron Institute of Oncology (VHIO)Hospital Vall d’Hebron, McGill University - Segal Cancer Center, McGill University - Segal Cancer Center, Tata Memorial Centre - Tata Memorial Hospital, Institut Mutualiste Montsouris, University of Claude Bernard Lyon 1 - Medical Oncology Department, École Normale Supérieure - PSL Research University - Institut Curie, Iuliu Hatieganu University of Medicine and Pharmacy, Ben-Gurion University of the NegevIuliu Hatieganu University of Medicine and Pharmacy, Ben-Gurion University of the NegevIuliu Hatieganu University of Medicine and Pharmacy, WIN Consortium - Worldwide Innovative Network (WIN) Association and WIN Consortium - Worldwide Innovative Network (WIN) Association
Downloads 32 (937,762)

Abstract:

Loading...

NSCLC, outcome , trascriptomics, DDPP, adjuvant therapies, precision medicine, WIN Consortium

3.

E-Health Intervention to Manage Skin Toxicity for Oncology Patients

Number of pages: 16 Posted: 06 Dec 2024
I.M. Sechenov First Moscow State Medical University, I.M. Sechenov First Moscow State Medical University, I.M. Sechenov First Moscow State Medical University, I.M. Sechenov First Moscow State Medical University, I.M. Sechenov First Moscow State Medical University and I.M. Sechenov First Moscow State Medical University
Downloads 22 (1,044,089)

Abstract:

Loading...

skin toxicity, patients support program, e-Health, dermatology life quality index, cancer therapy evaluation program.